Online CME: Generalized Anxiety Disorder

Article

Learn about three online CME programs that offer up to 8.5 CME credits, 5.5 of which are available for free.

Credits: 1.00

Fee: None

Expires: February 1, 2013

Multimedia: None

This activity was developed “to facilitate the highest quality professional work in clinical applications, teaching, consultation, or research.” Specifically, the program addresses brief interventions that may prevent further anxiety symptoms in children but not adults, appropriate instruments for screening for generalized anxiety disorder (GAD), hospitalization of patients with GAD who are suicidal, non-drug and drug therapy, the importance of patient education, follow-up care.Enter the below URL in your Web browser window, search for “generalized anxiety disorder,” and chose “physician” as your profession to access this course.

Click here to access this third-party resource.

Insights Into Generalized Anxiety Disorder

Credits: 4.50

Fee: None

Expires: April 30, 2012

Multimedia: None

How to recognize GAD, even when comorbid psychiatric conditions are present, how comorbid conditions affect the course of GAD and quality of life of those with the disorder, the neurobiology of patients with GAD and how it differs from people without GAD, available treatments for GAD, and individualized treatments for patients with refractory GAD form the focus of this program.

Click here to access this third-party resource.

Pharmacotherapy for Children and Adolescents with Anxiety Disorders

Credits: 3.00

Fee: $25.00

Expires: April 30, 2011

Multimedia: None

Part of a program that requires participants to read three other articles (“Pharmacotherapy for Pediatric Major Depression,” “Pharmacotherapy of Autism and Related Disorders,” and “Practical Guide to ADHD Pharmacotherapy”) before obtaining credit, this article reviews recent evidence on the effectiveness of pharmacotherapy for treating children and adolescents with anxiety disorders. Psychotropic medication for the treatment of pediatric anxiety disorders and the relative risks and benefits of medication use for children with anxiety disorders compared to psychotherapy alone or combined psychotherapy and medication.

Click here to access this third-party resource.

Related Videos
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
Depression Screening: Challenges and Solutions at the Primary Care Level
HCPLive Five at APA 2024 | Image Credit: HCPLive
John M. Oldham, MD: A History of Personality Disorder Pathology
Franklin King, MD: Psychedelic Therapy History, Advances, and Hurdles
Robert Weinrieb, MD: Psychiatry-Hepatology Approach for Alcohol-Related Liver Disease
© 2024 MJH Life Sciences

All rights reserved.